JBF Capital’s Metacrine, Inc. Common Stock MTCR Stock Holding History

JBF Capital’s Portfolio MTCR Stock Details MTCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,945,270	Closed	-$1.11M	–	88
2023 Q1	$1.11M	Buy	+1,945,270	New	+$913K	0.25%	27

JBF Capital's MTCR Position: Q2 2023 in Review

JBF Capital sold out of Metacrine, Inc. Common Stock (MTCR) in Q2 2023, closing a stake of 1,945,270 shares — an estimated $1.11M sold.

JBF Capital first reported a position in MTCR in Q1 2023 and held it in 1 quarter. The position peaked at $1.11M in Q1 2023. 0 funds tracked by Wall St. Rank hold MTCR as of Q2 2023.

JBF Capital reported no remaining Metacrine, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
JBF Capital sold 1,945,270 Metacrine, Inc. Common Stock shares in Q2 2023, an estimated $1.11M.
JBF Capital first reported a position in Metacrine, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
JBF Capital's Metacrine, Inc. Common Stock position peaked at $1.11M in Q1 2023.
0 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q2 2023.

Based on JBF Capital's 13F filing for Q2 2023, filed 11 Aug 2023.